IMARC Group, a leading market research company, has recently releases report titled “Cancer Immunotherapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global cancer immunotherapy market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How Big is the Cancer Immunotherapy Market?
The global cancer immunotherapy market size reached US$ 106.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 182.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028.
What is Cancer Immunotherapy?
Cancer immunotherapy is a treatment solution for people suffering from cancer diseases. It comprises antibodies that bind and inhibit the function of proteins expressed by cancer cells. It assists in enhancing the immune system and detecting and damaging abnormal cancer cells in the body. Besides this, it aids in lowering the chances of reoccurring cancer cells and has few side effects as compared to other treatment options. As a result, cancer immunotherapy is widely utilized to treat bladder, cervical, breast, lung, kidney, thyroid, melanoma, and liver cancers among individuals around the world.
Request Free Sample Copy of This Report: https://www.imarcgroup.com/cancer-immunotherapy-market/requestsample
What are the growth prospects and trends in the cancer immunotherapy industry?
At present, the rising demand for treatment solutions with fewer side effects among the masses represents one of the major factors bolstering the market growth. Besides this, the growing adoption of cancer immunotherapies due to the rising approval for the novel immunotherapies are offering a positive market outlook.
In line with this, the wide availability and easy access to medical insurance, along with the increasing healthcare expenditure, is strengthening the growth of the market. Moreover, various technological advancements in cancer treatment therapies to efficiently treat the disease are offering lucrative growth opportunities to industry investors.
Furthermore, the increasing number of cancer cases due to the rising consumption of toxic substances and unhealthy lifestyles of individuals is propelling the growth of the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Therapy Type:
- Monoclonal Antibodies
- Cancer Vaccines
- Checkpoint Inhibitors
- Immunomodulators
- Others
Breakup by Application:
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head and Neck Cancer
- Others
Breakup by End User:
- Hospitals
- Cancer Research Centers
- Clinics
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Amgen Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson Johnson, Merck KGAA, Novartis AG, Pfizer Inc., Sanofi, Seagen Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
